Current insight into the regulation of PD-L1 in cancer.

Publication Year: 2022

DOI:
10.1186/s40164-022-00297-8

PMCID:
PMC9338491

PMID:
35907881

Journal Information

Full Title: Exp Hematol Oncol

Abbreviation: Exp Hematol Oncol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported in part by the National Natural Science Foundation of China (No. 81770158, 82070152), the Pearl River S&T Nova Program of Guangzhou, China (No. 201906010002), Guangdong Province Science and Technology Project (No. 2020A0505100042) (No. 2020A1515110310), Guangdong Basic and Applied Basic Research Foundation (No. 2021A1515110140), Special Funds for the Cultivation of Guangdong College Students’ Scientific and Technological Innovation (“Climbing Program” Special Funds.) (No. pdjh2022a0055), and National Innovation and Entrepreneurship Training Program for Undergraduate (No. 202110559101) (No. 202210559061)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025